60 related articles for article (PubMed ID: 7536913)
1. [Epitopes of the envelope of the hepatitis B virus: a structural approach].
Lema F; Vulliez-Le Normand B; Saul F; Bentley G; Lecroisey A; Delepierre M
Pathol Biol (Paris); 1994 Oct; 42(8):761-6. PubMed ID: 7536913
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
4. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
5. [Study on HBV preS/S gene mutation in peripheral blood mononuclear cells].
Zhang L; He L; Yao X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):148-52. PubMed ID: 12569784
[TBL] [Abstract][Full Text] [Related]
6. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.
Cupps TR; Tibbles J; Hurni WM; Miller WJ; Ellis RW; Milich D; Wetter N
J Immunol; 1993 Sep; 151(6):3353-60. PubMed ID: 7690803
[TBL] [Abstract][Full Text] [Related]
7. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection.
Pollicino T; Campo S; Raimondo G
Virology; 1995 Apr; 208(2):672-7. PubMed ID: 7747438
[TBL] [Abstract][Full Text] [Related]
8. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
[TBL] [Abstract][Full Text] [Related]
9. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.
Candotti D; Grabarczyk P; Ghiazza P; Roig R; Casamitjana N; Iudicone P; Schmidt M; Bird A; Crookes R; Brojer E; Miceli M; Amiri A; Li C; Allain JP
J Hepatol; 2008 Oct; 49(4):537-47. PubMed ID: 18602718
[TBL] [Abstract][Full Text] [Related]
10. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
[TBL] [Abstract][Full Text] [Related]
11. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
[TBL] [Abstract][Full Text] [Related]
12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
13. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
[TBL] [Abstract][Full Text] [Related]
14. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
15. Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B.
Wu W; Chen Y; Ruan B; Li LJ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):530-4. PubMed ID: 16286257
[TBL] [Abstract][Full Text] [Related]
16. Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.
Abou-Jaoudé G; Molina S; Maurel P; Sureau C
Virology; 2007 Aug; 365(1):204-9. PubMed ID: 17462692
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
[TBL] [Abstract][Full Text] [Related]
18. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants.
Tai PC; Suk FM; Gerlich WH; Neurath AR; Shih C
Virology; 2002 Jan; 292(1):44-58. PubMed ID: 11878907
[TBL] [Abstract][Full Text] [Related]
19. Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
